Form 4: GeneDx Holdings CFO Kevin Feeley Sells Shares to Cover Tax Obligations After RSU Vesting
SEC Form 4 Filing
GeneDx Holdings CFO Kevin Feeley sold 3,728 shares of Class A Common Stock at $76.7541 per share to cover tax obligations following the vesting of restricted stock units.
Summary
- Kevin Feeley, the Chief Financial Officer of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock on December 16, 2024.
- Feeley acquired 7,197 shares of Class A Common Stock through the vesting of restricted stock units (RSUs) at no cost.
- Following the vesting, Feeley sold 3,728 shares of Class A Common Stock at a price of $76.7541 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of the RSUs and was not a discretionary sale.
- After these transactions, Feeley directly owns 28,200 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.
Industry Context
This is a routine transaction for company executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.
Comparison to Industry Standards
- The sale of shares to cover tax obligations is a standard practice among executives in publicly traded companies.
- Many companies use RSUs as part of their compensation packages, and the vesting and subsequent tax obligations are common occurrences.
- Similar transactions are regularly reported by executives at companies like Illumina, Invitae, and Exact Sciences, which are also in the genomics and diagnostics space.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not indicate any change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of the RSU vesting and subsequent sale of shares. |
| 12/18/2024 | Date the SEC Form 4 was signed. |
Keywords
GeneDx Holdings, Kevin Feeley, Class A Common Stock, Restricted Stock Units, RSU Vesting, Tax Withholding, SEC Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.